2024-10-012025-09-302025-09-30false14337050DOCTOR O'DONOVAN - MEDICAL EDUCATION LIMITED2025-12-01falseiso4217:GBPxbrli:pure143370502024-09-30143370502025-09-30143370502024-10-012025-09-30143370502023-09-30143370502024-09-30143370502023-10-012024-09-3014337050bus:SmallEntities2024-10-012025-09-3014337050bus:AuditExempt-NoAccountantsReport2024-10-012025-09-3014337050bus:FullAccounts2024-10-012025-09-3014337050bus:PrivateLimitedCompanyLtd2024-10-012025-09-3014337050core:WithinOneYear2025-09-3014337050core:AfterOneYear2025-09-3014337050core:WithinOneYear2024-09-3014337050core:AfterOneYear2024-09-3014337050core:ShareCapital2025-09-3014337050core:SharePremium2025-09-3014337050core:RevaluationReserve2025-09-3014337050core:OtherReservesSubtotal2025-09-3014337050core:RetainedEarningsAccumulatedLosses2025-09-3014337050core:ShareCapital2024-09-3014337050core:SharePremium2024-09-3014337050core:RevaluationReserve2024-09-3014337050core:OtherReservesSubtotal2024-09-3014337050core:RetainedEarningsAccumulatedLosses2024-09-3014337050core:LandBuildings2025-09-3014337050core:PlantMachinery2025-09-3014337050core:Vehicles2025-09-3014337050core:FurnitureFittings2025-09-3014337050core:OfficeEquipment2025-09-3014337050core:NetGoodwill2025-09-3014337050core:IntangibleAssetsOtherThanGoodwill2025-09-3014337050core:ListedExchangeTraded2025-09-3014337050core:UnlistedNon-exchangeTraded2025-09-3014337050core:LandBuildings2024-09-3014337050core:PlantMachinery2024-09-3014337050core:Vehicles2024-09-3014337050core:FurnitureFittings2024-09-3014337050core:OfficeEquipment2024-09-3014337050core:NetGoodwill2024-09-3014337050core:IntangibleAssetsOtherThanGoodwill2024-09-3014337050core:ListedExchangeTraded2024-09-3014337050core:UnlistedNon-exchangeTraded2024-09-3014337050core:LandBuildings2024-10-012025-09-3014337050core:PlantMachinery2024-10-012025-09-3014337050core:Vehicles2024-10-012025-09-3014337050core:FurnitureFittings2024-10-012025-09-3014337050core:OfficeEquipment2024-10-012025-09-3014337050core:NetGoodwill2024-10-012025-09-3014337050core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3014337050core:ListedExchangeTraded2024-10-012025-09-3014337050core:UnlistedNon-exchangeTraded2024-10-012025-09-3014337050core:MoreThanFiveYears2024-10-012025-09-3014337050core:Non-currentFinancialInstruments2025-09-3014337050core:Non-currentFinancialInstruments2024-09-3014337050dpl:CostSales2024-10-012025-09-3014337050dpl:DistributionCosts2024-10-012025-09-3014337050core:LandBuildings2024-10-012025-09-3014337050core:PlantMachinery2024-10-012025-09-3014337050core:Vehicles2024-10-012025-09-3014337050core:FurnitureFittings2024-10-012025-09-3014337050core:OfficeEquipment2024-10-012025-09-3014337050dpl:AdministrativeExpenses2024-10-012025-09-3014337050core:NetGoodwill2024-10-012025-09-3014337050core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3014337050dpl:GroupUndertakings2024-10-012025-09-3014337050dpl:ParticipatingInterests2024-10-012025-09-3014337050dpl:GroupUndertakingscore:ListedExchangeTraded2024-10-012025-09-3014337050core:ListedExchangeTraded2024-10-012025-09-3014337050dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-10-012025-09-3014337050core:UnlistedNon-exchangeTraded2024-10-012025-09-3014337050dpl:CostSales2023-10-012024-09-3014337050dpl:DistributionCosts2023-10-012024-09-3014337050core:LandBuildings2023-10-012024-09-3014337050core:PlantMachinery2023-10-012024-09-3014337050core:Vehicles2023-10-012024-09-3014337050core:FurnitureFittings2023-10-012024-09-3014337050core:OfficeEquipment2023-10-012024-09-3014337050dpl:AdministrativeExpenses2023-10-012024-09-3014337050core:NetGoodwill2023-10-012024-09-3014337050core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3014337050dpl:GroupUndertakings2023-10-012024-09-3014337050dpl:ParticipatingInterests2023-10-012024-09-3014337050dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3014337050core:ListedExchangeTraded2023-10-012024-09-3014337050dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3014337050core:UnlistedNon-exchangeTraded2023-10-012024-09-3014337050core:NetGoodwill2025-09-3014337050core:IntangibleAssetsOtherThanGoodwill2025-09-3014337050core:LandBuildings2025-09-3014337050core:PlantMachinery2025-09-3014337050core:Vehicles2025-09-3014337050core:FurnitureFittings2025-09-3014337050core:OfficeEquipment2025-09-3014337050core:AfterOneYear2025-09-3014337050core:WithinOneYear2025-09-3014337050core:ListedExchangeTraded2025-09-3014337050core:UnlistedNon-exchangeTraded2025-09-3014337050core:ShareCapital2025-09-3014337050core:SharePremium2025-09-3014337050core:RevaluationReserve2025-09-3014337050core:OtherReservesSubtotal2025-09-3014337050core:RetainedEarningsAccumulatedLosses2025-09-3014337050core:NetGoodwill2024-09-3014337050core:IntangibleAssetsOtherThanGoodwill2024-09-3014337050core:LandBuildings2024-09-3014337050core:PlantMachinery2024-09-3014337050core:Vehicles2024-09-3014337050core:FurnitureFittings2024-09-3014337050core:OfficeEquipment2024-09-3014337050core:AfterOneYear2024-09-3014337050core:WithinOneYear2024-09-3014337050core:ListedExchangeTraded2024-09-3014337050core:UnlistedNon-exchangeTraded2024-09-3014337050core:ShareCapital2024-09-3014337050core:SharePremium2024-09-3014337050core:RevaluationReserve2024-09-3014337050core:OtherReservesSubtotal2024-09-3014337050core:RetainedEarningsAccumulatedLosses2024-09-3014337050core:NetGoodwill2023-09-3014337050core:IntangibleAssetsOtherThanGoodwill2023-09-3014337050core:LandBuildings2023-09-3014337050core:PlantMachinery2023-09-3014337050core:Vehicles2023-09-3014337050core:FurnitureFittings2023-09-3014337050core:OfficeEquipment2023-09-3014337050core:AfterOneYear2023-09-3014337050core:WithinOneYear2023-09-3014337050core:ListedExchangeTraded2023-09-3014337050core:UnlistedNon-exchangeTraded2023-09-3014337050core:ShareCapital2023-09-3014337050core:SharePremium2023-09-3014337050core:RevaluationReserve2023-09-3014337050core:OtherReservesSubtotal2023-09-3014337050core:RetainedEarningsAccumulatedLosses2023-09-3014337050core:AfterOneYear2024-10-012025-09-3014337050core:WithinOneYear2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:CostValuation2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3014337050core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3014337050core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3014337050core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3014337050core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3014337050core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3014337050bus:Director12024-10-012025-09-30

DOCTOR O'DONOVAN - MEDICAL EDUCATION LIMITED

Registered Number
14337050
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

DOCTOR O'DONOVAN - MEDICAL EDUCATION LIMITED
Company Information
for the year from 1 October 2024 to 30 September 2025

Director

O'DONOVAN, James Joseph, Dr

Registered Address

Unit G21 Eleventh Avenue North
Team Valley Trading Estate
Gateshead
NE11 0NJ

Registered Number

14337050 (England and Wales)
DOCTOR O'DONOVAN - MEDICAL EDUCATION LIMITED
Balance Sheet as at
30 September 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets33,9584,388
3,9584,388
Current assets
Debtors1,3604,807
Cash at bank and on hand69,92654,883
71,28659,690
Creditors amounts falling due within one year4(7,359)(8,683)
Net current assets (liabilities)63,92751,007
Total assets less current liabilities67,88555,395
Net assets67,88555,395
Capital and reserves
Called up share capital100100
Profit and loss account67,78555,295
Shareholders' funds67,88555,395
The financial statements were approved and authorised for issue by the Director on 1 December 2025, and are signed on its behalf by:
O'DONOVAN, James Joseph, Dr
Director
Registered Company No. 14337050
DOCTOR O'DONOVAN - MEDICAL EDUCATION LIMITED
Notes to the Financial Statements
for the year ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 October 245,3165,316
Additions734734
At 30 September 256,0506,050
Depreciation and impairment
At 01 October 24928928
Charge for year1,1641,164
At 30 September 252,0922,092
Net book value
At 30 September 253,9583,958
At 30 September 244,3884,388
4.Creditors: amounts due within one year

2025

2024

££
Amounts owed to related parties3,5753,560
Taxation and social security3,1484,523
Accrued liabilities and deferred income636600
Total7,3598,683
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.